Stoykow C - Search Results

1

Results from extended lymphadenectomies with [¹¹¹In]PSMA-617 for intraoperative detection of PSMA-PET/CT-positive nodal metastatic prostate cancer.

Jilg CA, Reichel K, Stoykow C, Rischke HC, Bartholomä M, Drendel V, von Büren M, Schultze-Seemann W, Meyer PT, Mix M. Jilg CA, et al. Among authors: stoykow c. EJNMMI Res. 2020 Mar 6;10(1):17. doi: 10.1186/s13550-020-0598-2. EJNMMI Res. 2020. PMID: 32144598 Free PMC article.

2

Performance of ¹¹¹In-labelled PSMA ligand in patients with nodal metastatic prostate cancer: correlation between tracer uptake and histopathology from lymphadenectomy.

Mix M, Reichel K, Stoykow C, Bartholomä M, Drendel V, Gourni E, Wetterauer U, Schultze-Seemann W, Meyer PT, Jilg CA. Mix M, et al. Among authors: stoykow c. Eur J Nucl Med Mol Imaging. 2018 Nov;45(12):2062-2070. doi: 10.1007/s00259-018-4094-0. Epub 2018 Jul 30. Eur J Nucl Med Mol Imaging. 2018. PMID: 30062606 Free article.

3

Gastrin-releasing Peptide Receptor Imaging in Breast Cancer Using the Receptor Antagonist (68)Ga-RM2 And PET.

Stoykow C, Erbes T, Maecke HR, Bulla S, Bartholomä M, Mayer S, Drendel V, Bronsert P, Werner M, Gitsch G, Weber WA, Stickeler E, Meyer PT. Stoykow C, et al. Theranostics. 2016 Jun 19;6(10):1641-50. doi: 10.7150/thno.14958. eCollection 2016. Theranostics. 2016. PMID: 27446498 Free PMC article.

4

Strong PSMA Radioligand Uptake by Rectal Carcinoma: Who Put the "S" in PSMA?

Stoykow C, Huber-Schumacher S, Almanasreh N, Jilg C, Ruf J. Stoykow C, et al. Clin Nucl Med. 2017 Mar;42(3):225-226. doi: 10.1097/RLU.0000000000001484. Clin Nucl Med. 2017. PMID: 27997423

5

Effect of radiochemotherapy on T2* MRI in HNSCC and its relation to FMISO PET derived hypoxia and FDG PET.

Wiedenmann N, Bunea H, Rischke HC, Bunea A, Majerus L, Bielak L, Protopopov A, Ludwig U, Büchert M, Stoykow C, Nicolay NH, Weber WA, Mix M, Meyer PT, Hennig J, Bock M, Grosu AL. Wiedenmann N, et al. Among authors: stoykow c. Radiat Oncol. 2018 Aug 29;13(1):159. doi: 10.1186/s13014-018-1103-1. Radiat Oncol. 2018. PMID: 30157883 Free PMC article.

6

Correction to: Effect of radiochemotherapy on T2* MRI in HNSCC and its relation to FMISO PET derived hypoxia and FDG PET.

Wiedenmann N, Bunea H, Rischke HC, Bunea A, Majerus L, Bielak L, Protopopov A, Ludwig U, Büchert M, Stoykow C, Nicolay NH, Weber WA, Mix M, Meyer PT, Hennig J, Bock M, Grosu AL. Wiedenmann N, et al. Among authors: stoykow c. Radiat Oncol. 2018 Sep 21;13(1):183. doi: 10.1186/s13014-018-1134-7. Radiat Oncol. 2018. PMID: 30241555 Free PMC article.

7

Textural features of hypoxia PET predict survival in head and neck cancer during chemoradiotherapy.

Sörensen A, Carles M, Bunea H, Majerus L, Stoykow C, Nicolay NH, Wiedenmann NE, Vaupel P, Meyer PT, Grosu AL, Mix M. Sörensen A, et al. Among authors: stoykow c. Eur J Nucl Med Mol Imaging. 2020 May;47(5):1056-1064. doi: 10.1007/s00259-019-04609-9. Epub 2019 Nov 26. Eur J Nucl Med Mol Imaging. 2020. PMID: 31773233 Clinical Trial.

8

Association between gastrin-releasing peptide receptor expression as assessed with [⁶⁸Ga]Ga-RM2 PET/CT and histopathological tumor regression after neoadjuvant chemotherapy in primary breast cancer.

Michalski K, Stoykow C, Bronsert P, Juhasz-Böss I, Meyer PT, Ruf J, Erbes T, Asberger J. Michalski K, et al. Among authors: stoykow c. Nucl Med Biol. 2020 Jul-Aug;86-87:37-43. doi: 10.1016/j.nucmedbio.2020.05.003. Epub 2020 May 12. Nucl Med Biol. 2020. PMID: 32473549

9

Detection of Insulinomas Using Dual-Time-Point 68Ga-DOTA-Exendin 4 PET/CT.

Michalski K, Laubner K, Stoykow C, Omrane MA, Maecke HR, Seufert J, Goetz C, Meyer PT, Ruf J. Michalski K, et al. Among authors: stoykow c. Clin Nucl Med. 2020 Jul;45(7):519-524. doi: 10.1097/RLU.0000000000003093. Clin Nucl Med. 2020. PMID: 32453080

10

Quantification of Tumor Oxygenation Based on FMISO PET: Influence of Location and Oxygen Level of the Well-Oxygenated Reference Region.

Lazzeroni M, Toma-Dasu I, Ureba A, Schiavo F, Wiedenmann N, Bunea H, Thomann B, Baltas D, Mix M, Stoykow C, Sörensen A, Grosu AL. Lazzeroni M, et al. Among authors: stoykow c. Adv Exp Med Biol. 2020;1232:177-182. doi: 10.1007/978-3-030-34461-0_22. Adv Exp Med Biol. 2020. PMID: 31893408

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

14 results

Search Page